SLC7A11 and head and neck cancer: demonstrated that both genetic silencing of the SLC7A11 gene and pharmacological inhibition of xCT by sulfasalazine significantly sensitized cisplatin‐resistant head and neck cancer cells by inducing ferroptosis [27].